These early studies identified high-penetrance susceptibility genes for breast cancer (BRCA1 and BRCA2) [5–7], colorectal cancer (APC, MLH1, MSH2) [8–12] and melanoma (CDKN2A) [13–15]. This evidence concerns the gene BRCA2 and breast carcinoma.